News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

Elan (ELN) Dendreon (DNDN) BIOMARIN (BMRN) Endometrial Cancer NANTKWEST (NK) Intercept (ICPT) Biocryst (BCRX) Dynavax (DVAX) ZALTRAP™ OSI (OSIP) Array Pharmaceuticals (ARRY) SERES THERAPEUTICS (MCRB) Human Longevity (HLI) INNOVIVA (INVA) galapagos (GLPG) GUARDIAN HEALTH TOKAI (TKAOI) Agenus (AGEN) Spike Therapeutics (ONCE) Pluristem (PSTI) ImmunoGen (IMGN) GlaxoSmithKline (GSK) Vitae Pharmaceuticals (VTAE) ACADIA (ACAD) Sarepta (SRPT) Micromet (MITI) Inovio (INO) Exelixis (EXEL) Intrexon (XON) SUNESIS PHARMACEUTICALS (SNSS) Jazz Pharmaceuticals (JAZZ) Anacor (ANAC) JUNO (JUNO) Aimmune Therapeutics (AIMT) Trastuzumab-DM1 Genentech ISIS (ISIS) Roche (ROCHE) Global Cell Therapeutics (GBT) Roche (RHHBY) Galena (GALE) Prosensa (RNA) CompuGen (CGEN) HALOZYME (HALO) Sanofi (SNY) REGULUS (RGLS) Revlimid (lenolidamide) PTC Therapeutics (PTCT) Sequenom (SQNM) SYNTA (SNTA) Abbott Laboratories (ABT) Telaprevir Amgen (AMGN) ADVENTRIX (ANX) ABBVIE (ABBV) KITE (KITE) Editas (EDIT) Rapamune IDERA (IDRA) Biogen Idec (BIIB) Herceptin Velcade (bortezomib) Zerenex Ariad (ARIA) Multiple Myeloma RenenxBio (RGNX) Gilead (GILD) Bristol-Myers Squibb (BMY) Anadys (ANDS) Ridaforolimus Xoma (XOMA) Idenix (IDIX) Seattle Genetics (SGEN) Theravance (THRX) Alnylam (ALNY) Mirati Therapeutics (MRTX) ARCA (ABIO) Auspex (ASPX) VANDA (VNDA) Incyte (INCY) Human Genome Sciences (HGSI) Onyx (ONXX) Intermune (ITMN) Alder Biopharmaceuticals (ALDR) Sangamo (SGMO) KERYX (KERX) Merck (MRK) ARGOS (ARGS) C4 Therapeutics Ionis (IONS) Valeant Pharmaceuticals International (VRX) Sanofi-Aventis (SAN) Vertex (VRTX) AGOS (ARGS) Illumina (ILMN) AERIE PHARMACEUTICALS Ziofpharm (ZIOP) Benlysta (belimumab) Tysabri Regeneron (REGN) NEKTAR (NKTR)) Prolor Biotech (PBTH) Cytokinetics (CYTK) Theravance Bio Pharma (TBPH) Agenus (AGEN Sanofi (SNA)